ISSN: 0009-9236

Journal Home

Journal Guideline

Clinical Pharmacology and Therapeutics Q1 Unclaimed

Wiley-Blackwell United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Clinical Pharmacology and Therapeutics is a journal indexed in SJR in Pharmacology and Pharmacology (medical) with an H index of 209. It has an SJR impact factor of 1,988 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,988.

Clinical Pharmacology and Therapeutics focuses its scope in these topics and keywords: acid, cysteine, drug, clinical, medicines, variability, role, study, trials, allelic, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pharmacology (Q1) Pharmacology (medical) (Q1) Pharmacology (medical) (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

1,988

SJR Impact factor

209

H Index

300

Total Docs (Last Year)

955

Total Docs (3 years)

11855

Total Refs

4985

Total Cites (3 years)

800

Citable Docs (3 years)

5.46

Cites/Doc (2 years)

39.52

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Pharmacological Reviews Q1
Drug Resistance Updates Q1
Annual Review of Pharmacology and Toxicology Q1
Molecular Therapy Q1
Journal for ImmunoTherapy of Cancer Q1

Compare this journals

Aims and Scope

Best articles by citations

A novel PD model for gatifloxacin (GF) vs. salmonella typhi (ST) in timed kill curves (KC)

Nelfinavir and felodipine: a cytochrome P450 3A4?mediated drug interaction

Effects of age and gender on the pharmacokinetics of lonafarnib (L) following a single oral dose

Enhanced stimulant and metabolic effects of combined ephedrine and caffeine*1

Ethical issues in research with healthy volunteers: risk-benefit assessment

Disposition of Acetaminophen at 4, 6, and 8g/day for 3 Days in Healthy Young Adults

Hair cortisol - a potential biological marker for chronic stress

Comparison of genotypic and phenotypic strategies for individualized therapy with the narrow therapeutic drug warfarin

The impact of timing of chemotherapy relative to darbepoetin alfa (DA) on DA pharmacokinetics (PK) and hematologic effects

Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin

Gene expression profiles of 4-hydroxy-N-desmethyl-tamoxifen (endoxifen)- and 4-hydroxy-tamoxifen (4OHTAM)-treated human breast cancer cells determined by CDNA microarray analysis

Platelet serotonin (5-HT) reuptake for biomarking SSRI therapeutics in adolescents

SHOW MORE ARTICLES

Ammonia-Lowering Strategies for the Treatment of Hepatic Encephalopathy

Cytochrome P450 eicosanoids regulate fatty acid metabolism via PPARa

Obituary

Implication of cholesterol in cyclosporine pharmacodynamics in minimal change nephrotic syndrome

Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone*

Human liver cytochrome P450 2D6 genotype, full-length messenger ribonucleic acid, and activity assessed with a novel cytochrome P450 2D6 substrate*1

Application of a map Bayesian method for CYP2E1 phenotyping

Pharmacokinetics (PK) of lonafarnib (L), a farnesyl protein transferase inhibitor

N-terminal pro-BNP is a possible early biomarker for the cardiac side-effects of anthracyclines

Severe neutropenia among healthy volunteers given rifabutin in clinical trials

Delayed disposition of cocaine in sweat patches and in skin blister: cocaine may migrate from plasma to sweat patches via interstitial fluid

Ephedra and caffeine produce insulin resistance and hypokalemia in healthy subjects